Ledyard National Bank’s AbbVie ABBV Stock Holding History

Ledyard National Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.3M	Sell	17,080 -773	-4%	-$166K	0.34%	60
2026 Q1	$3.88M	Sell	17,853 -963	-5%	-$214K	0.34%	61
2025 Q4	$4.3M	Sell	18,816 -821	-4%	-$187K	0.37%	58
2025 Q3	$4.55M	Buy	19,637 +36	+0.2%	+$7.33K	0.41%	55
2025 Q2	$3.64M	Sell	19,601 -88	-0.4%	-$16.4K	0.34%	64
2025 Q1	$4.13M	Sell	19,689 -965	-5%	-$188K	0.41%	57
2024 Q4	$3.67M	Buy	20,654 +28	+0.1%	+$5.15K	0.35%	63
2024 Q3	$4.07M	Buy	20,626 +787	+4%	+$147K	0.37%	61
2024 Q2	$3.4M	Buy	19,839 +58	+0.3%	+$9.61K	0.33%	63
2024 Q1	$3.6M	Sell	19,781 -105	-0.5%	-$18.1K	0.35%	65
2023 Q4	$3.08M	Buy	19,886 +2,859	+17%	+$417K	0.32%	66
2023 Q3	$2.54M	Sell	17,027 -8	-0%	-$1.17K	0.29%	71
2023 Q2	$2.3M	Sell	17,035 -279	-2%	-$40.9K	0.25%	77
2023 Q1	$2.76M	Sell	17,314 -555	-3%	-$84.8K	0.32%	71
2022 Q4	$2.89M	Sell	17,869 -110	-0.6%	-$16.9K	0.34%	71
2022 Q3	$2.41M	Sell	17,979 -494	-3%	-$70.9K	0.31%	75
2022 Q2	$2.83M	Sell	18,473 -1,045	-5%	-$160K	0.34%	76
2022 Q1	$3.16M	Sell	19,518 -385	-2%	-$55.9K	0.32%	78
2021 Q4	$2.69M	Sell	19,903 -2,662	-12%	-$314K	0.26%	83
2021 Q3	$2.43M	Sell	22,565 -2,489	-10%	-$284K	0.25%	84
2021 Q2	$2.82M	Sell	25,054 -426	-2%	-$48K	0.29%	82
2021 Q1	$2.76M	Buy	25,480 +2,168	+9%	+$232K	0.3%	81
2020 Q4	$2.5M	Sell	23,312 -740	-3%	-$71.1K	0.29%	84
2020 Q3	$2.11M	Sell	24,052 -498	-2%	-$46.9K	0.27%	85
2020 Q2	$2.41M	Buy	24,550 +48	+0.2%	+$4.23K	0.32%	80
2020 Q1	$1.87M	Sell	24,502 -653	-3%	-$55.6K	0.29%	93
2019 Q4	$2.23M	Buy	25,155 +99	+0.4%	+$8.22K	0.27%	98
2019 Q3	$1.9M	Sell	25,056 -790	-3%	-$54.2K	0.25%	100
2019 Q2	$1.88M	Sell	25,846 -1,060	-4%	-$83.3K	0.25%	103
2019 Q1	$2.17M	Sell	26,906 -1,275	-5%	-$104K	0.29%	99
2018 Q4	$2.6M	Sell	28,181 -316	-1%	-$27.8K	0.34%	93
2018 Q3	$2.69M	Sell	28,497 -466	-2%	-$44.2K	0.31%	99
2018 Q2	$2.68M	Sell	28,963 -905	-3%	-$88.4K	0.32%	96
2018 Q1	$2.83M	Sell	29,868 -37	-0.1%	-$4.07K	0.34%	90
2017 Q4	$2.89M	Sell	29,905 -2,553	-8%	-$241K	0.35%	88
2017 Q3	$2.88M	Buy	32,458 +12,626	+64%	+$961K	0.38%	88
2017 Q2	$1.44M	Buy	19,832 +1,439	+8%	+$96.7K	0.21%	108
2017 Q1	$1.2M	Buy	18,393 +3,890	+27%	+$245K	0.18%	112
2016 Q4	$908K	Buy	14,503 +225	+2%	+$13.7K	0.16%	106
2016 Q3	$901K	Buy	14,278 +170	+1%	+$11K	0.16%	107
2016 Q2	$874K	Buy	14,108 +1,000	+8%	+$60.9K	0.16%	110
2016 Q1	$749K	Sell	13,108 -72	-0.5%	-$4.01K	0.13%	118
2015 Q4	$781K	Hold	13,180	–	–	0.14%	112
2015 Q3	$717K	Buy	13,180 +72	+0.5%	+$4.69K	0.14%	108
2015 Q2	$881K	Buy	13,108 +140	+1%	+$9.14K	0.15%	104
2015 Q1	$759K	Sell	12,968 -140	-1%	-$8.46K	0.14%	109
2014 Q4	$857K	Sell	13,108 -505	-4%	-$31.8K	0.16%	98
2014 Q3	$786K	Buy	13,613 +205	+2%	+$11.4K	0.15%	96
2014 Q2	$757K	Sell	13,408 -21	-0.2%	-$1.1K	0.13%	98
2014 Q1	$690K	Sell	13,429 -439	-3%	-$22.2K	0.12%	100
2013 Q4	$733K	Sell	13,868 -197	-1%	-$9.68K	0.12%	94
2013 Q3	$629K	Sell	14,065 -755	-5%	-$33.5K	0.11%	93
2013 Q2	$613K	Buy	+14,820	New	+$648K	0.11%	87

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Ledyard National Bank's ABBV Position: Q2 2026 in Review

Ledyard National Bank reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $166K and leaving 17,080 shares worth $4.3M. The position accounts for 0.34% of the portfolio, ranked #60.

Ledyard National Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.55M in Q3 2025. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ledyard National Bank held 17,080 shares of AbbVie worth $4.3M as of Q2 2026.
Ledyard National Bank sold 773 AbbVie shares in Q2 2026, an estimated $166K.
AbbVie made up 0.34% of Ledyard National Bank's portfolio in Q2 2026, its #60 holding.
Ledyard National Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Ledyard National Bank's AbbVie position peaked at $4.55M in Q3 2025.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.